1. Home
  2. ARQT vs NG Comparison

ARQT vs NG Comparison

Compare ARQT & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • NG
  • Stock Information
  • Founded
  • ARQT 2016
  • NG 1984
  • Country
  • ARQT United States
  • NG Canada
  • Employees
  • ARQT N/A
  • NG N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • NG Precious Metals
  • Sector
  • ARQT Health Care
  • NG Basic Materials
  • Exchange
  • ARQT Nasdaq
  • NG Nasdaq
  • Market Cap
  • ARQT 1.1B
  • NG 1.2B
  • IPO Year
  • ARQT 2020
  • NG N/A
  • Fundamental
  • Price
  • ARQT $12.68
  • NG $3.29
  • Analyst Decision
  • ARQT Strong Buy
  • NG
  • Analyst Count
  • ARQT 5
  • NG 0
  • Target Price
  • ARQT $17.00
  • NG N/A
  • AVG Volume (30 Days)
  • ARQT 2.1M
  • NG 1.6M
  • Earning Date
  • ARQT 02-25-2025
  • NG 01-23-2025
  • Dividend Yield
  • ARQT N/A
  • NG N/A
  • EPS Growth
  • ARQT N/A
  • NG N/A
  • EPS
  • ARQT N/A
  • NG N/A
  • Revenue
  • ARQT $138,708,000.00
  • NG N/A
  • Revenue This Year
  • ARQT $209.03
  • NG N/A
  • Revenue Next Year
  • ARQT $49.00
  • NG N/A
  • P/E Ratio
  • ARQT N/A
  • NG N/A
  • Revenue Growth
  • ARQT 182.84
  • NG N/A
  • 52 Week Low
  • ARQT $3.11
  • NG $2.23
  • 52 Week High
  • ARQT $16.20
  • NG $4.88
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 43.06
  • NG 44.64
  • Support Level
  • ARQT $13.10
  • NG $3.24
  • Resistance Level
  • ARQT $14.36
  • NG $3.39
  • Average True Range (ATR)
  • ARQT 0.99
  • NG 0.13
  • MACD
  • ARQT -0.32
  • NG 0.00
  • Stochastic Oscillator
  • ARQT 1.95
  • NG 30.26

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About NG Novagold Resources Inc.

Novagold Resources Inc is a mineral exploration company engaged in the exploration and development of mineral properties. The company owns 50% of the Donlin Gold project, which is located in southwestern Alaska, approximately 20 kilometers north of the village of Crooked Creek on the Kuskokwim River.

Share on Social Networks: